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Diabetes is well-established to be a major healthcare problem.  Preclinical and clinical data 
suggest that diabetes influences the heart and may be associated with cardiac repolarisation 
abnormalities and pro-arrhythmia.  For example, a recent (2017) retrospective review of 
patients admitted to hospital at least twice in a 4-year period with type 1 or 2 diabetes, 
found prolonged rate-corrected (QTc) QT intervals in ~67 % of type 1 and ~51 % of type 2 
patients (Lu et al., 2017).  In the same study, more than 60 % of diabetic patients exhibited a 
modest, but significant reduction in left ventricular ejection fraction (LVEF) between first 
and second admissions (Lu et al., 2017).  In preclinical experiments, potassium channel 
current reduction has been reported in ventricular myocytes from type 2 diabetic (db/db) 
male but not female mice of 12 weeks of age (Shimoni et al., 2004); this suggests that type 2 
diabetes in mice is associated with sex-specific K+ channel remodelling.  However, the 
relevance of such findings to human diabetes is unclear because small rodents and humans 
rely on different K+ channels for ventricular repolarisation.  In contrast, whilst in vivo 
measurements from rabbits with type 2 diabetes induced by a high fat diet have shown QTc 
interval prolongation and augmented QT interval dispersion (Zarzoso et al., 2014), 
corresponding in vitro measurements from isolated hearts with normal extracellular 
potassium showed no changes in repolarisation, suggesting that (an) extrinsic factor(s) may 
be involved in producing repolarisation abnormalities in that model (Zarzoso et al., 2014).  
This differs from data from a rabbit model of type 1 diabetes, showing both QTc 
prolongation and reduced ventricular rapid delayed rectifier K+ current, IKr, attributed to 
oxidative stress damage to the myocardium and reversible with insulin (Zhang et al., 2006).  
Of course, what is really needed to understand effects of diabetes on human ventricular 
repolarisation and arrhythmia risk is information on ion channel/transporter function in 
human ventricular myocardium.  This is problematic, however, due to issues in obtaining 
2 
 
and making measurements from human healthy control and diabetic ventricular tissue.  In 
this volume of the journal, Ashrafi et al (2017) have taken an alternative approach to the 
issue: measurement of myocardial gene expression from type 2 diabetic patients 
undergoing surgery for aortic valve replacement, with controls represented by patients 
undergoing the same surgery, but lacking type 2 diabetes.  The combination of this 
approach with computer modelling has given rise to potentially important new information 
on proarrhythmic electrical remodelling in human type 2 diabetes (Ashrafi et al, 2017). 
 
In this new study, left ventricular myocardial biopsies were taken from 9 control and 7 
diabetic patients at the time of aortic valve surgery and quantitative polymerise chain 
reaction (qPCR) was used to measure levels mRNA for a range of major ion channels and 
transporters (Ashrafi et al, 2017).  QTc intervals for control and diabetic groups were 451 ms 
and 467 ms respectively.  Modest changes (up to ± 26%) in mRNA for a number of ion 
channel subunits were found, with substantial changes observed for three genes.  Thus, 
mRNA levels for hERG (the human Ether-à-Go-Go-related Gene encoded IKr channel α-
subunit) were decreased by ~65%, whilst those for KCNJ2 encoded Kir2.1 (a key component 
of channels responsible for inwardly rectifying K+ current, IK1) were increased by ~85% and 
for the cardiac isoform of the sodium-calcium exchanger (NCX1) by ~244%.  The relevant 
current densities in ventricular epicardial and endocardial action potential (AP) models were 
then scaled by the observed % differences in mRNA levels.  Both epi- and endocardial 
‘diabetic’ APs were longer than control APs.  Additionally, the modelled endocardial APs 
exhibited cellular pro-arrhythmic events, early after-depolarisations (EADs).  Further 
simulations were performed in which changes to individual conductances were incorporated 
and these revealed that the most functionally significant changes were those to IKr and NCX 
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current.  Altered IK1 had only a small effect - a small acceleration of terminal repolarisation.  
The two groups of subjects were similar in terms of age, left-ventricular ejection fraction, 
and drug treatments (metformin and sulphonylureas aside).  For both groups longitudinal 
strain values fell into a range consistent with the presence of some fibrosis, albeit with a 
slightly lower longitudinal strain value for the diabetes group.   Thus, the differences in gene 
expression and corresponding electrophysiological simulations were considered to be a 
consequence of diabetes/hyperglycaemia rather than caused by a pathway linked to fibrosis 
and left-ventricular hypertrophy (Ashrafi et al, 2017).  
 
Whilst some caution is warranted in interpreting simulation results based on mRNA data 
alone, without corresponding protein expression or function data, the approaches adopted 
in the study by Ashrafi and colleagues are justified in light of the challenges in obtaining the 
required comparative functional data from human ventricular myocytes.  Their results are 
consistent with human type 2 diabetes leading to an “acquired” form of QTc interval 
prolongation akin to that produced by hERG blocking drugs (Hancox et al., 2008), potentially 
exacerbated by NCX-linked changes in Ca2+ handling.  This could have important implications 
in terms of arrhythmia risk and drug selection for such patients.  However, as the authors 
acknowledge, the sample sizes here are relatively small and the subjects elderly (mean ages 
of >70 for both groups).  Future work is needed to determine whether these results are 
borne out by studies of larger diabetic cohorts and for subjects of different ages.  Also, there 
are intrinsic differences in repolarisation between males and females (James et al., 2007) 
and the study of larger control and diabetic cohorts would enable evaluation of sex-linked 
differences in type 2 diabetic remodelling.  The results presented here provide an important 
platform upon which such larger studies can build.  They also provide a basis for the 
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selection for mechanistic studies of animal models that mimic most closely the ion 
channel/transporter remodelling seen here for humans.  This study also lays the foundation 
for further future simulation work: to determine model-dependence of the delayed 
repolarisation seen here; to investigate rate dependence of the observed effects and, at the 
‘intact’ tissue level, to probe arrhythmia mechanisms and to explore the potential for 
antiarrhythmic approaches targeted to specific diabetic remodelling.   
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